FB2026_03 , released September 17, 2026
Human Disease Model Report: episodic kinesigenic dyskinesia, KCNJ10-related
Open Close
General Information
Name
episodic kinesigenic dyskinesia, KCNJ10-related
FlyBase ID
FBhh0001614
Disease Ontology Term
Parent Disease
OMIM
Overview

This report concerns a newly described autosomal dominant episodic kinesigenic dyskinesia, also described as paroxysmal kinesigenic dyskinesia (EKD/PKD). The gene implicated in this disease is KCNJ10, which encodes an inwardly rectifying potassium channel. KCNJ10 is also implicated in several autosomal recessive diseases (MIM:602208); see the FlyBase Human Disease report for EAST syndrome (FBhh0001613). Both human and Drosophila have multiple genes that encode inwardly rectifying potassium channels. The Drosophila gene Irk2 has been used in a study of this disease.

A UAS construct of wild-type Hsap\KCNJ10 has been introduced into flies. Heterologous rescue (functional complementation) has been demonstrated for mutations of Dmel\Irk2.

Mutations analogous to the KCNJ10 variants associated with episodic kinesigenic dyskinesia have been introduced into Dmel\Irk2; see the 'Disease-Implicate Variants' table below. For several assayed phenotypes, animal heterozygous for the Irk2 mutation exhibit a phenotype intermediate between that observed for wild-type and for homozygous Irk2 mutant animals. These results support the hypothesis that the KCNJ10 heterozygous variants cause EKD due to effects of haploinsufficiency, rather than through a dominant-negative mechanism.

One of the variants characterized in this study has also been implicated (when homozygous) in EAST syndrome (see FBhh0001613).

[updated Jan. 2025 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: dystonia
Symptoms and phenotype

Dystonia describes a neurologic condition characterized by involuntary, sustained muscle contractions affecting one or more sites of the body; 'torsion' refers to the twisting nature of body movements observed in some types of dystonia. Dystonia has been classified as primary (dystonia as the sole or major symptom) or secondary (a symptom of another disorder), and by age of onset, muscle groups affected, and mode of inheritance (Muller and Kupke, 1990, pubmed:2404852; Nemeth, 2002, pubmed:11912106). [from MIM:128100; 15.07.07]

Dystonic movements are typically patterned, twisting, and may be tremulous. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation. Dystonias are classified by several clinical characteristics including age of onset (infancy (birth to 2 years), childhood (3-12 years), adolescence (13-20 years), early adulthood (21-40 years), and late adulthood (over 40 years)), temporal pattern (static or progressive disease course and the variability of symptoms, which may persist, fluctuate diurnally or occur only with specific actions or in paroxysms), by body distribution, which is divided into focal (affecting a single body part), segmental (affecting two or more contiguous muscle groups, multifocal (affecting two or more non-contiguous muscle groups), hemidystonia (affecting an arm and a leg on one side of the body), or generalized (affecting the trunk and two or more other sites), and by coexistence of other movement disorders. (Balint and Bhatia, 2014, PMID:24978640, Gene_reviews, Dystonia Overview, 2015.07.09)

Specific Disease Summary: episodic kinesigenic dyskinesia, KCNJ10-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype

Episodic kinesigenic choreoathetosis (EKD/PKD) is an autosomal dominant neurologic condition characterized by recurrent and brief attacks of involuntary movement triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. Symptoms become less severe with age and show favorable response to anticonvulsant medications. [from MIM:128200; 2025.01.20]

Genetics

In 11 individuals diagnosed with EKD/PKD, from 8 unrelated families, heterozygous variants in KCNJ10 were identified (Li et al., 2024; pubmed:38979912; FBrf0260825).

In a separate study identifying variants of KCNJ10 associated with autosomal dominant episodic kinesigenic dyskinesia, one case of recessive EKD/PKD associated with a homozygous KCNJ10 variant was reported (Wirth et al., 2024; pubmed:38436103).

In both of the studies cited above, cases of individuals with EAST syndrome or EKD/PKD within the same family were observed.

Cellular phenotype and pathology
Molecular information

KCNJ10 encodes a member of the inward rectifier-type potassium channel family, characterized by having a greater tendency to allow potassium to flow into, rather than out of, a cell. May be responsible for potassium buffering action of glial cells in the brain. [GeneCards, KCNJ10; 2025.01.20]

External links
Disease synonyms
dystonia, familial paroxysmal
EKD
EKD/PKD
paroxysmal kinesigenic dyskinesia, KCNJ10-related
PKD
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to many: multiple related genes in human and Drosophila.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      Inwardly rectifying potassium channel 2 (Irk2) encodes a protein that is required in transepithelial fluid secretion and potassium transport in the Malpighian tubule. It contributes to wing patterning, through the regulation of release of the product of dpp. [Date last reviewed: 2018-11-08]
      Cellular component (GO)
      Gene Groups / Pathways
      Comments on ortholog(s)

      Multiple related genes in both human and Drosophila; Dmel\Irk2 is most closely related to most of the human genes.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (1 groups)
        protein-protein
        Interacting group
        Assay
        References
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (7 alleles)
        Models Based on Experimental Evidence ( 6 )
        Modifiers Based on Experimental Evidence ( 2 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        loss of function allele
        CRISPR/Cas9
        CRISPR/Cas9
        CRISPR/Cas9
        CRISPR/Cas9
        CRISPR/Cas9
        CRISPR/Cas9
        References (5)